Divi's Laboratories Limited (NSE:DIVISLAB)

Divi's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	32,610	4,150	3,630	1,700	12,148	20,303
Short-Term Investments	-	31,120	33,350	39,630	15,269	505
Cash & Short-Term Investments	32,610	35,270	36,980	41,330	27,417	20,808
Cash Growth	-9.47%	-4.62%	-10.53%	50.75%	31.76%	102.91%
Accounts Receivable	26,140	27,310	21,560	17,930	24,239	16,765
Other Receivables	-	2,470	2,050	1,410	1,045	1,018
Receivables	26,140	29,780	23,610	19,340	25,283	17,783
Inventory	34,330	32,360	31,840	30,000	28,286	21,452
Prepaid Expenses	-	370	360	260	270.9	225
Other Current Assets	5,350	3,030	3,960	2,190	2,258	1,479
Total Current Assets	98,430	100,810	96,750	93,120	83,515	61,747
Property, Plant & Equipment	77,040	64,600	55,130	49,290	47,875	44,095
Long-Term Investments	670	650	820	770	720.1	0.1
Other Intangible Assets	40	40	40	50	74.9	49.5
Long-Term Deferred Tax Assets	120	110	100	140	144.7	32.3
Other Long-Term Assets	5,210	3,110	1,860	1,020	1,418	1,816
Total Assets	181,510	169,320	154,700	144,390	133,747	107,741
Accounts Payable	10,400	9,100	8,240	7,620	7,957	7,632
Accrued Expenses	620	3,460	2,440	2,550	3,235	2,486
Short-Term Debt	890	20	-	-	-	3.5
Current Portion of Leases	10	-	10	10	8.2	7.9
Current Income Taxes Payable	450	-	430	20	16.8	59.8
Current Unearned Revenue	-	10	10	10	7.6	6.4
Other Current Liabilities	4,910	1,930	1,650	800	731.3	929.3
Total Current Liabilities	17,280	14,520	12,780	11,010	11,956	11,125
Long-Term Leases	-	20	20	30	28.7	36.9
Long-Term Deferred Tax Liabilities	5,120	5,090	5,820	5,370	4,214	3,381
Other Long-Term Liabilities	4,980	-	370	310	267.1	252.5
Total Liabilities	27,380	19,630	18,990	16,720	16,465	14,795
Common Stock	530	530	530	530	530.9	530.9
Additional Paid-In Capital	-	800	800	800	798.8	798.8
Retained Earnings	-	148,050	134,120	126,090	115,797	91,480
Comprehensive Income & Other	153,600	310	260	250	155.1	136.3
Shareholders' Equity	154,130	149,690	135,710	127,670	117,282	92,946
Total Liabilities & Equity	181,510	169,320	154,700	144,390	133,747	107,741
Total Debt	900	40	30	40	36.9	48.3
Net Cash (Debt)	31,710	35,230	36,950	41,290	27,380	20,760
Net Cash Growth	-11.77%	-4.66%	-10.51%	50.80%	31.89%	110.41%
Net Cash Per Share	119.43	132.71	139.19	155.54	103.14	78.20
Filing Date Shares Outstanding	265.31	265.47	265.47	265.47	265.47	265.47
Total Common Shares Outstanding	265.31	265.47	265.47	265.47	265.47	265.47
Working Capital	81,150	86,290	83,970	82,110	71,560	50,623
Book Value Per Share	580.95	563.87	511.21	480.92	441.79	350.12
Tangible Book Value	154,090	149,650	135,670	127,620	117,207	92,897
Tangible Book Value Per Share	580.80	563.72	511.06	480.73	441.51	349.93
Land	-	2,020	1,950	1,940	1,727	1,715
Machinery	-	55,000	48,630	45,770	39,860	33,535
Construction In Progress	-	10,220	7,780	2,120	4,699	7,106

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.